OCULAR HYPERTENSION
Clinical trials for OCULAR HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new OCULAR HYPERTENSION trials appear
Sign up with your email to follow new studies for OCULAR HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Glaucoma Drop-Free lens fails to launch – early trial halted
Disease control TerminatedThis study tested a special contact lens that slowly releases glaucoma medication (latanoprost) to lower eye pressure. The goal was to see if the lens is safe, comfortable, and works as well as standard eye drops. Only 1 person took part before the study was stopped early, so we …
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated May 26, 2026 05:44 UTC
-
Glaucoma combo drop study halted early
Disease control TerminatedThis study tested two different combinations of eye drops to lower eye pressure in people with open-angle glaucoma or ocular hypertension. The goal was to see which combination worked better over 90 days. The study was stopped early and included 28 participants.
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE4 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Tiny drops, big hope: new device could change glaucoma treatment
Symptom relief TerminatedThis study tested a device called Nanodropper that makes smaller eye drops for people with glaucoma or high eye pressure. The goal was to see if these smaller drops lower eye pressure just as well as standard drops. The study planned to include 16 adults who already use a common …
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated May 26, 2026 04:38 UTC